Aid and Tylenol now united after $48.7 billion Kimberly-Clark and Kenvue merger. Explore what this means for consumers and the market.

Kimberly-Clark's (KMB.O) nearly $50 billion offer for Tylenol maker Kenvue (KVUE.N) is a risky bet that the world's biggest consumer market, the United States, will keep growing even as lower-income ...